PAPER Labandeira-Garcia JL, Rodriguez-Pallares J, Rodríguez-Perez AI, Garrido-Gil P, Villar-Cheda B, Valenzuela R, Guerra MJ
SEARCH RESULTS
331009 RESULTS
PAPER Zhou YF, Liao SS, Luo YY, Tang JG, Wang JL, Lei LF, Chi JW, Du J, Jiang H, Xia K, Tang BS, Shen L
SUMO-1 modification on K166 of polyQ-expanded ataxin-3 strengthens its stability and increases its cytotoxicity.
PLoS One. 2013;8(1):e54214. PubMed: 23382880PAPER Kolarcik CL, Bowser R
Retinoid signaling alterations in amyotrophic lateral sclerosis.
Am J Neurodegener Dis. 2012;1(2):130-45. PubMed: 23383387PAPER Mizwicki MT, Fiala M, Magpantay L, Aziz N, Sayre J, Liu G, Siani A, Chan D, Martinez-Maza O, Chattopadhyay M, La Cava A
Tocilizumab attenuates inflammation in ALS patients through inhibition of IL6 receptor signaling.
Am J Neurodegener Dis. 2012;1(3):305-15. PubMed: 23383400PAPER Yi J, Zhang L, Tang B, Han W, Zhou Y, Chen Z, Jia D, Jiang H
Sodium valproate alleviates neurodegeneration in SCA3/MJD via suppressing apoptosis and rescuing the hypoacetylation levels of histone H3 and H4.
PLoS One. 2013;8(1):e54792. PubMed: 23382971PAPER Mori K, Lammich S, Mackenzie IR, Forné I, Zilow S, Kretzschmar H, Edbauer D, Janssens J, Kleinberger G, Cruts M, Herms J, Neumann M, Van Broeckhoven C, Arzberger T, Haass C
hnRNP A3 binds to GGGGCC repeats and is a constituent of p62-positive/TDP43-negative inclusions in the hippocampus of patients with C9orf72 mutations.
Acta Neuropathol. 2013 Mar;125(3):413-23. PubMed: 23381195PAPER Paine SM, Anderson G, Bedford K, Lawler K, Mayer RJ, Lowe J, Bedford L
Pale body-like inclusion formation and neurodegeneration following depletion of 26S proteasomes in mouse brain neurones are independent of α-synuclein.
PLoS One. 2013;8(1):e54711. PubMed: 23382946PAPER Arnold ES, Ling SC, Huelga SC, Lagier-Tourenne C, Polymenidou M, Ditsworth D, Kordasiewicz HB, McAlonis-Downes M, Platoshyn O, Parone PA, Da Cruz S, Clutario KM, Swing D, Tessarollo L, Marsala M, Shaw CE, Yeo GW, Cleveland DW
ALS-linked TDP-43 mutations produce aberrant RNA splicing and adult-onset motor neuron disease without aggregation or loss of nuclear TDP-43.
Proc Natl Acad Sci U S A. 2013 Feb 19;110(8):E736-45. PubMed: 23382207PAPER Bandiera S, Cartault F, Jannot AS, Hatem E, Girard M, Rifai L, Loiseau C, Munnich A, Lyonnet S, Henrion-Caude A
Genetic variations creating microRNA target sites in the FXN 3'-UTR affect frataxin expression in Friedreich ataxia.
PLoS One. 2013;8(1):e54791. PubMed: 23382970PAPER Ahn TB, Langston JW, Aachi VR, Dickson DW
Relationship of neighboring tissue and gliosis to α-synuclein pathology in a fetal transplant for Parkinson's disease.
Am J Neurodegener Dis. 2012;1(1):49-59. PubMed: 23383381PAPER Ghidoni R, Paterlini A, Benussi L
Circulating progranulin as a biomarker for neurodegenerative diseases.
Am J Neurodegener Dis. 2012;1(2):180-90. PubMed: 23383391PAPER Perez PD, Hall G, Kimura T, Ren Y, Bailey RM, Lewis J, Febo M, Sahara N
In vivo functional brain mapping in a conditional mouse model of human tauopathy (tau(P301L)) reveals reduced neural activity in memory formation structures.
Mol Neurodegener. 2013;8:9. PubMed: 23379588PAPER Wickner RB, Edskes HK, Bateman DA, Kelly AC, Gorkovskiy A, Dayani Y, Zhou A
Amyloids and yeast prion biology.
Biochemistry. 2013 Mar 5;52(9):1514-27. PubMed: 23379365PAPER Honarnejad K, Jung CK, Lammich S, Arzberger T, Kretzschmar H, Herms J
Involvement of presenilin holoprotein upregulation in calcium dyshomeostasis of Alzheimer's disease.
J Cell Mol Med. 2013 Feb;17(2):293-302. PubMed: 23379308PAPER Haldar S, Beveridge AJ, Wong J, Singh A, Galimberti D, Borroni B, Zhu X, Blevins J, Greenlee J, Perry G, Mukhopadhyay CK, Schmotzer C, Singh N
A Low-Molecular-Weight Ferroxidase Is Increased in the CSF of sCJD Cases: CSF Ferroxidase and Transferrin as Diagnostic Biomarkers for sCJD.
Antioxid Redox Signal. 2013 Apr 16; PubMed: 23379482Current Filters
No filters selected